A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>A mutation.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28166746)

Published in BMC Neurol on February 06, 2017

Authors

Han-Jui Lee1,2, Ting-Rong Hsu3,4, S-C Hung5, Wen-Chung Yu2,6, Tzu-Hung Chu2,4, Chia-Feng Yang2,4, Svetlana Bizjajeva7, Chui-Mei Tiu1,2, Dau-Ming Niu8,9

Author Affiliations

1: Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
2: School of Medicine, National Yang-Ming University, Taipei, Taiwan.
3: Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
4: Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan.
5: From the Departments of Radiology (H.-J.L., S.-C.H., T.C.-M.) School of Medicine (H.-J.L., S.-C.H., T.-R.H., S.-C.K., T.C.-M., C.-C.H., D.-M.N., C.-P.L.) Department of Biomedical Imaging and Radiological Sciences (S.-C.H., C.-C.H., C.-P.L.), National Yang-Ming University, Taipei, Taiwan.
6: Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
7: Shire, Zug, Switzerland.
8: Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan. dmniu1111@yahoo.com.tw.
9: Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan. dmniu1111@yahoo.com.tw.

Articles cited by this

Prevalence of lysosomal storage disorders. JAMA (1999) 9.06

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol (1987) 8.48

Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol (2003) 7.05

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest (2004) 4.54

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data. Lancet (2009) 4.02

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet (2001) 3.45

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet (2005) 2.59

An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med (1991) 2.27

High-resolution computed tomography of the basilar artery: 2. Vertebrobasilar dolichoectasia: clinical-pathologic correlation and review. AJNR Am J Neuroradiol (1986) 2.25

Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant (2009) 2.17

Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A). Hum Mutat (2009) 1.78

Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke (2009) 1.52

Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol (2003) 1.44

High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet (2009) 1.39

CNS manifestations of Fabry's disease. Lancet Neurol (2006) 1.29

Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study. J Neurol Neurosurg Psychiatry (2008) 1.19

Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study. J Cardiol (2008) 1.16

T1 hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease. AJNR Am J Neuroradiol (2003) 1.14

Enzyme replacement therapy with agalsidase alfa in children with Fabry disease. Acta Paediatr (2007) 1.14

A new phenotype of Fabry disease with intermediate severity between the classical form and the cardiac variant. Contrib Nephrol (2001) 1.02

Fabry disease: immunocytochemical characterization of neuronal involvement. Ann Neurol (1992) 1.00

Cognitive dysfunction and depression in Fabry disease: a systematic review. J Inherit Metab Dis (2013) 0.98

Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey. Clin Genet (2011) 0.92

α-Galactosidase A knockout mice: progressive organ pathology resembles the type 2 later-onset phenotype of Fabry disease. Am J Pathol (2014) 0.89

Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset Fabry mutation (IVS4 + 919G > A). Orphanet J Rare Dis (2014) 0.87

Basilar artery diameter is a potential screening tool for Fabry disease in young stroke patients. Cerebrovasc Dis (2010) 0.86

Natural history of the cerebrovascular complications of Fabry disease. Acta Paediatr Suppl (2005) 0.85

Cerebrovascular involvement in Fabry disease: current status of knowledge. Stroke (2014) 0.83

Brain MR Imaging Findings of Cardiac-Type Fabry Disease with an IVS4+919G>A Mutation. AJNR Am J Neuroradiol (2016) 0.77